Young Saing Kim

1.9k total citations
78 papers, 1.4k citations indexed

About

Young Saing Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Young Saing Kim has authored 78 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 25 papers in Surgery. Recurrent topics in Young Saing Kim's work include Lung Cancer Treatments and Mutations (12 papers), Nutrition and Health in Aging (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). Young Saing Kim is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Nutrition and Health in Aging (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). Young Saing Kim collaborates with scholars based in South Korea, United States and Belgium. Young Saing Kim's co-authors include Eun Young Kim, Hee Kyung Ahn, Inkeun Park, Eun Kyung Cho, Yu Mi Jeong, Dong Bok Shin, Jeong Ho Kim, Se Hoon Park, Jinny Park and Junshik Hong and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Young Saing Kim

74 papers receiving 1.4k citations

Peers

Young Saing Kim

ONCOL

PRM

PHYSI

SURGE

G. Albrand France

Narhari Timilshina Canada

Cecilia G. Ethun United States

Stephen T. McSorley United Kingdom

I. Monteiro Grillo Portugal

Gabriella Farina Italy

S. Klapper United States

Dattatraya Patil United States

Jingjie Xiao Canada

Massimo Maffezzini Italy

G. Albrand France

Young Saing Kim

498 ×0.9

ONCOL

389 ×0.8

PRM

422 ×0.9

PHYSI

319 ×1.0

SURGE

518 ×2.5

Citations per year, relative to Young Saing Kim Young Saing Kim (= 1×) peers G. Albrand

Countries citing papers authored by Young Saing Kim

Since Specialization

Citations

This map shows the geographic impact of Young Saing Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Saing Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Saing Kim more than expected).

Fields of papers citing papers by Young Saing Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young Saing Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Saing Kim. The network helps show where Young Saing Kim may publish in the future.

Co-authorship network of co-authors of Young Saing Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Young Saing Kim. A scholar is included among the top collaborators of Young Saing Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young Saing Kim. Young Saing Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Young Saing, Keon Uk Park, Jang Ho Cho, et al.. (2024). Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18. JTO Clinical and Research Reports. 5(12). 100734–100734. 1 indexed citations

Kim, Yu Jung, Koung Jin Suh, Se Hyun Kim, et al.. (2024). Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second‐line treatment (EAGLES, Korean Cancer Study Group UN18‐06). Cancer. 131(1). e35609–e35609. 2 indexed citations

Lee, Seok Ho, et al.. (2021). A rare malignant periurethral carcinosarcoma with aggressive behavior: A case treated with a multimodal treatment approach. Urology Case Reports. 38. 101699–101699.

Kim, Young Saing, Inkeun Park, Hee Kyung Ahn, et al.. (2021). Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy. American Journal of Clinical Oncology. 44(6). 232–238. 5 indexed citations

Kim, Eun Young, Young Jae Kim, Young Saing Kim, et al.. (2021). Prognostic significance of radiodensity-based skeletal muscle quantification using preoperative CT in resected non-small cell lung cancer. Journal of Thoracic Disease. 13(2). 754–761. 13 indexed citations

Lee, Jong Soo, Eun Young Kim, Kwang Gi Kim, et al.. (2021). Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer. Thoracic Cancer. 12(11). 1662–1667. 12 indexed citations

Kim, Eun Young, Young Sup Shim, Young Saing Kim, et al.. (2019). Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010–2012. PLoS ONE. 14(10). e0224224–e0224224. 14 indexed citations

Kim, Young Saing, et al.. (2018). Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer. PLoS ONE. 13(8). e0202700–e0202700. 94 indexed citations

Lee, Kwang Beom, Young Saing Kim, & Jong‐Min Lee. (2017). Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB–IIA cervical cancer patients. Journal of Gynecologic Oncology. 29(1). e5–e5. 5 indexed citations

10.

Hwang, In Gyu, Moon Jin Kim, Se Hoon Park, et al.. (2016). Factors Influencing Clinicians' Choice of Adjuvant S-1 versus Capecitabine plus Oxaliplatin after Curative Gastrectomy in Patients with Gastric Cancer. Journal of Cancer. 7(12). 1711–1715. 4 indexed citations

11.

Kim, Eun Young, Young Saing Kim, Inkeun Park, et al.. (2016). Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT. Supportive Care in Cancer. 24(11). 4721–4726. 54 indexed citations

12.

Kim, Young Saing, In Gyu Hwang, Se‐Il Go, et al.. (2016). Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma. Cancer Chemotherapy and Pharmacology. 77(5). 979–985. 25 indexed citations

13.

Kim, Young Saing, Eun Kyung Cho, Junshik Hong, et al.. (2015). Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer. Cancer Research and Treatment. 48(1). 80–87. 13 indexed citations

14.

Kim, Young Saing, Sun Jin Sym, Inkeun Park, et al.. (2015). Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study. Cancer Chemotherapy and Pharmacology. 76(6). 1267–1272. 6 indexed citations

15.

Kim, Hyun‐Jun, Young Saing Kim, & Se Hoon Park. (2015). Opioid rotation versus combination for cancer patients with chronic uncontrolled pain: a randomized study. BMC Palliative Care. 14(1). 41–41. 23 indexed citations

16.

Kim, Eun Young, Young Saing Kim, Inkeun Park, et al.. (2015). Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(12). 1795–1799. 188 indexed citations

17.

Ahn, Hee Kyung, Ha Yeon Lee, Inkeun Park, et al.. (2014). Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors. Investigational New Drugs. 32(6). 1311–1315. 23 indexed citations

18.

Kim, Young Saing, Jun Ho Ji, Young Hyeh Ko, Seok Jin Kim, & Won Seog Kim. (2013). Matched-Pair Analysis Comparing the Outcomes of T Cell/Histiocyte-Rich Large B Cell Lymphoma and Diffuse Large B Cell Lymphoma in Patients Treated with Rituximab-CHOP. Acta Haematologica. 131(3). 156–161. 5 indexed citations

19.

Kim, Young Saing, Sun Jin Sym, Se Hoon Park, et al.. (2013). A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 73(1). 163–169. 18 indexed citations

20.

Park, Se Hoon, Junshik Hong, Young Saing Kim, et al.. (2008). Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer. Lung Cancer. 62(1). 72–77. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact